News from WuXi AppTec A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

15 May, 2017, 09:42 ET WuXi AppTec Completes Acquisition of HD Biosciences

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that...


29 Mar, 2017, 20:00 ET WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec Affiliate, today...


26 Mar, 2017, 20:00 ET LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

LabNetwork, WuXi AppTec's global chemistry ecommerce platform company, today announced a new collaboration with Elsevier, a world-leading provider...


28 Feb, 2017, 19:00 ET WuXi AppTec Lab Testing Division's Bioanalytical Service Unit Passed FDA Inspection

WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform company, today...


19 Jan, 2017, 12:52 ET WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

SHANGHAI, Jan. 19, 2017 /PRNewswire -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and...


18 Jan, 2017, 05:00 ET Novel Anti-IL-6 Antibody for Rheumatoid Arthritis from WuXi-MedImmune Joint Venture Receives Clinical Trial Permit (CTP) from CFDA

Milestone represents first-time approval of biologics CTP for a joint multinational-local company venture in China WuXi AppTec, a global R&D...


22 Nov, 2016, 19:00 ET WuXi Biologics and Prima Signs MOU and Announces Strategic Development and Manufacturing Partnership

WuXi Biologics, a WuXi AppTec group company and a leading open-access R&D capability and technology platform company dedicated to expediting...


06 Oct, 2016, 16:00 ET WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies

 WuXi AppTec (WuXi), a leading pharmaceutical, biotechnology, and medical device technology platform company, celebrated the grand opening of...


22 Sep, 2016, 08:00 ET WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreactors

 WuXi Biologics, a leading open-access R&D capability and technology platform company dedicated to biologics and a WuXi AppTec company,...


09 Sep, 2016, 08:00 ET WuXi AppTec Lab Testing Division and AutoGenomics Form Strategic Partnership to Introduce Advanced Molecular Diagnostic Technology to China

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and...


15 Aug, 2016, 08:00 ET WuXi AppTec's STA Subsidiary Passed Third U.S. FDA Inspection

WuXi AppTec Co. Ltd. (WuXi), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology,...


08 Aug, 2016, 08:00 ET WuXi AppTec's STA Subsidiary Opens Operations in San Diego

 WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology...


01 Aug, 2016, 08:00 ET WuXi AppTec's Research Service Division Collaborates with Pelago Bioscience to Provide CETSA® based Target Engagement Assays

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and...


27 Apr, 2016, 04:18 ET LabNetwork Forges eCommerce Alliances with Leading Chemical Providers

LabNetwork, a WuXi AppTec company, held a formal signing ceremony in Shanghai announcing strategic cooperation agreements with 8 top-ranking global...


26 Apr, 2016, 02:00 ET LabNetwork Announces Groundbreaking eCommerce Alliances

LabNetwork, a WuXi AppTec company, held a formal signing ceremony in Shanghai announcing strategic cooperation agreements with 10 top-ranking...


25 Mar, 2016, 08:30 ET WuXi Biologics Congratulates Ambrx and ZMC for Successful Dosing of a Novel Antibody-Drug Conjugate in Australia

 WuXi Biologics, a wholly-owned subsidiary of WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform...


25 Mar, 2016, 08:00 ET WuXi AppTec Launches South Korea Branch

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology and...


04 Mar, 2016, 08:00 ET WuXi AppTec's STA Subsidiary Opens New Campus in Changzhou

WuXi AppTec Co. Ltd. (WuXi), a leading open-access R&D capability and technology platform company serving the...


18 Feb, 2016, 08:00 ET WuXi AppTec Releases New Mobile App for Compounds Sourcing

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical...


02 Feb, 2016, 20:35 ET WuXi AppTec Congratulates MSD on Receiving FDA Approval of ZEPATIER(TM)

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and...


08 Jan, 2016, 08:00 ET WuXi AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and...


23 Dec, 2015, 11:36 ET WuXi AppTec Denies Issuing Press Release Regarding Great Basin Scientific

WuXi AppTec (WuXi), a leading open-access R&D capability and technology platform company serving the global pharmaceutical, biotechnology, and...